Marlene Debel - 01 Jun 2026 Form 4 Insider Report for METLIFE INC (MET)

Reporting relationship: EVP & Chief Risk Officer
Issuer ticker: MET
Reported as of: 01 Jun 2026
Net transaction value: -$1,738,823
SEC form: 4
Accepted by SEC: 03 Jun 2026, 16:07:36 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact

Key filing fact

Marlene Debel filed Form 4 for METLIFE INC (MET) on 03 Jun 2026.

Key facts

This page summarizes Marlene Debel's Form 4 filing for METLIFE INC (MET).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 16:07.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: -$1,738,823.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001770295 Primary reporting owner

DEBEL MARLENE

Relationship: EVP & Chief Risk Officer
Address: METLIFE, INC., 200 PARK AVENUE, NEW YORK
Signature: /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MET transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,600
Change %: +6.9%
Price: $46.85^*
Shares after: 164,980
Date: 01 Jun 2026
Ownership: Direct

MET transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,712
Change %: +6.5%
Price: $45.50^*
Shares after: 175,692
Date: 01 Jun 2026
Ownership: Direct

MET transaction

Common Stock

Sale

Transaction value: $1,738,823
Shares: -21,312
Change %: -12%
Price: $81.59
Shares after: 154,380
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MET transaction Derivative

Employee Stock Options (right to buy)

Options Exercise

Transaction value
Shares: -10,600
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,600
Exercise price: $46.85
Footnotes: F2

MET transaction Derivative

Employee Stock Options (right to buy)

Options Exercise

Transaction value
Shares: -10,712
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,712
Exercise price: $45.50
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Footnote F2

The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.

Footnote F3

The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.